Acute phase proteins (APPs) are pivotal biomarkers in veterinary medicine, reflecting the intrinsic link between inflammation, infection and tissue injury in diverse animal species. Produced primarily ...
Revuforj shows a 63.9% overall response rate in relapsed/refractory KMT2Ar acute leukemia, with significant MRD negativity and HSCT progression rates. The AUGMENT-101 trial reports a median duration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback